aprindine has been researched along with Central Nervous System Disease in 1 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aprindine was effective in five cases, and it failed in two." | 5.27 | Aprindine therapy for refractory ventricular tachycardia. ( Carleton, RA; Chown, M; Khan, AH, 1983) |
| "Aprindine was effective in five cases, and it failed in two." | 1.27 | Aprindine therapy for refractory ventricular tachycardia. ( Carleton, RA; Chown, M; Khan, AH, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, AH | 1 |
| Carleton, RA | 1 |
| Chown, M | 1 |
1 other study available for aprindine and Central Nervous System Disease
| Article | Year |
|---|---|
Aprindine therapy for refractory ventricular tachycardia.
Topics: Agranulocytosis; Aprindine; Central Nervous System Diseases; Electrocardiography; Follow-Up Studies; | 1983 |